The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists

The presented expert paper discusses the high prevalence of hypercholesterolemia (HCH) in Russia. Insufficient use of lipid-lowering therapy in both primary and secondary prevention is indicated. Failure to achieve the target level of low-density lipoprotein cholesterol (HC) and low adherence (espec...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Marina G. Bubnova, Albert S. Galyаvich, Marat V. Ezhov, David M. Aronov, Natalia N. Vinogradova, Gagik R. Galstyan, Viktor S Gurevich, Yuri A. Karpov, Natalia A. Koziolova, Elena D. Kosmacheva, Gennady V. Matyushin, Igor V. Sergienko, Alexander E. Philippov, Iurii Sh. Khalimov
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Concilium Medicum 2025-01-01
Цуврал:	КардиоСоматика
Нөхцлүүд:	atherosclerosis cardiovascular diseases prevention lipid-lowering therapy statins pitavastatin
Онлайн хандалт:	https://cardiosomatics.ru/2221-7185/article/viewFile/676903/198223
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!